Literature DB >> 4082752

Humoral immunity induced by a live Francisella tularensis vaccine. Complement fixing antibodies determined by an enzyme-linked immunosorbent assay (CF-ELISA).

P Koskela.   

Abstract

A complement-fixing enzyme-linked immunosorbent assay (CF-ELISA) with bacterial sonicate as the antigen, human AB serum as the source of complement and alkaline-phosphatase-labelled anti-(human C3c) as the conjugate was developed for detecting antibodies to Francisella tularensis. Humoral responses after inoculation with a live attenuated tularemia vaccine were studied in 13 subjects by this method. Twelve responded with CF antibodies, which in most cases appeared 4 weeks after vaccination, the response time varying from 1 week to 2 months. The highest individual CF titres, of 140-9990, were reached 1-4 months after vaccination (average 2.4 months). The CF titres tended to decrease with time, and at 10 months two of the 12 subjects with an earlier CF positive response were negative again. CF antibodies were nevertheless still detectable in all three subjects studied 1.5 years after vaccination.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4082752     DOI: 10.1016/0264-410x(85)90129-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Francisella tularensis enters macrophages via a novel process involving pseudopod loops.

Authors:  Daniel L Clemens; Bai-Yu Lee; Marcus A Horwitz
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Differential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensis.

Authors:  Constantine Bitsaktsis; Deepak B Rawool; Ying Li; Nitin V Kurkure; Bibiana Iglesias; Edmund J Gosselin
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

3.  An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes.

Authors:  Marcela F Pasetti; Lilian Cuberos; Thomas L Horn; Jeffry D Shearer; Stephen J Matthews; Robert V House; Marcelo B Sztein
Journal:  Vaccine       Date:  2008-01-29       Impact factor: 3.641

Review 4.  Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

Authors:  Lydia M Roberts; Daniel A Powell; Jeffrey A Frelinger
Journal:  Front Cell Infect Microbiol       Date:  2018-04-06       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.